PMID: 7541898Mar 1, 1995Paper

Inhibition of nitric oxide synthase activity in cerebral cortical synaptosomes by nitric oxide donors: evidence for feedback autoregulation

Neurochemical Research
T W Vickroy, W L Malphurs

Abstract

Despite evidence which supports a neurotransmitter-like role for nitric oxide (NO) in the CNS, relatively little is known regarding mechanisms which control NO formation within CNS neurons. In this study, isolated nerve endings (synaptosomes) from rat cerebral cortex were used to ascertain whether NO can autoregulate its own formation within neurons through feedback inhibition of the NO biosynthetic enzyme nitric oxide synthase (NOS). Under the conditions described here, N omega-nitro-L-arginine methyl ester-sensitive conversion of L-[3H]arginine into L-[3H]citrulline (i.e., NOS activity) was found to be highly calcium-dependent and strongly inhibited (up to 60 percent) by NO donors, including sodium nitroprusside, hydroxylamine and nitroglycerin. The inhibitory effect of sodium nitroprusside was concentration-dependent (IC50 approximately 100 microM) and prevented by the NO scavenger oxyhemoglobin. L-Citrulline, the other major end-product from NOS, had no apparent effect on synaptosomal NOS activity. Taken together, these results indicate that neuronal NOS can be inhibited by NO released from exogenous donors and, therefore, may be subject to end-product feedback inhibition by NO that is formed locally within neurons or relea...Continue Reading

References

Apr 25, 1977·Biochemical and Biophysical Research Communications·N MikiK Kuriyama
Nov 15, 1992·The Biochemical Journal·P KlattB Mayer
Nov 30, 1992·Biochemical and Biophysical Research Communications·N E Rogers, L J Ignarro
Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K McMillanB S Masters
Jan 1, 1992·Neuron·D S Bredt, S H Snyder
Feb 14, 1992·Biochemical and Biophysical Research Communications·L Agulló, A García
Jul 28, 1992·Biochemistry·K A White, M A Marletta
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D S Bredt, S H Snyder
Jul 1, 1990·The Biochemical Journal·R G KnowlesS Moncada
Jan 1, 1990·Annals of the New York Academy of Sciences·S Kalsner
Oct 30, 1990·Biochemical and Biophysical Research Communications·V MollaceJ Vane
Oct 17, 1989·European Journal of Pharmacology·J GarthwaiteS Moncada
Jul 1, 1989·Physiological Reviews·K StarkeH Kilbinger
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D S Bredt, S H Snyder
Mar 1, 1993·British Journal of Pharmacology·J AssreuyS Moncada
Jun 1, 1993·European Journal of Immunology·F Q CunhaS Moncada
Nov 1, 1993·Circulation Research·G M BugaL J Ignarro

❮ Previous
Next ❯

Citations

May 12, 2000·Critical Care Medicine·L LiaudetC Szabó
Feb 4, 2005·Cephalalgia : an International Journal of Headache·N OffenhauserU Reuter
May 28, 2010·American Journal of Physiology. Cell Physiology·Jiaguo ZhouR Daniel Peluffo
Dec 1, 1996·Neurochemical Research·C R Aldridge, K J Collard
Mar 21, 2000·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·F A SehbaJ B Bederson
May 9, 2006·Medicine and Science in Sports and Exercise·Robert C HicknerMichael McCammon
Oct 12, 1999·The American Journal of Physiology·M KurjakH D Allescher
Dec 26, 2001·Chemical Reviews·A Y Louie, T J Meade

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.